These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18633172)

  • 21. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of insulin resistance and the serum adiponectin level in patients with type 2 diabetes mellitus under the usual antihypertensive dosage of telmisartan treatment.
    Fuke Y; Fujita T; Satomura A; Wada Y; Matsumoto K
    Diabetes Technol Ther; 2010 May; 12(5):393-8. PubMed ID: 20388049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
    Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension.
    Hermida RC; Ayala DE; Fernández JR; Calvo C
    Hypertension; 2007 Oct; 50(4):715-22. PubMed ID: 17635851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis of randomized trials of telmisartan versus active controls for insulin resistance in hypertensive patients.
    Takagi H; Umemoto T;
    J Am Soc Hypertens; 2014 Aug; 8(8):578-92. PubMed ID: 25151319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients.
    Aoki A; Ogawa T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Nitta K
    Heart Vessels; 2010 May; 25(3):195-202. PubMed ID: 20512446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
    Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
    Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of randomized head-to-head trials of telmisartan versus other angiotensin II receptor blocker in combination with hydrochlorothiazide for reduction of blood pressure.
    Takagi H; Mizuno Y; Goto SN; Umemoto T;
    Int J Cardiol; 2013 Sep; 167(6):3062-5. PubMed ID: 23200265
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension.
    Mattioli AV; Bonatti S; Monopoli D; Zennaro M; Mattioli G
    Blood Press; 2005; 14(5):273-8. PubMed ID: 16257872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study.
    Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S;
    Hypertens Res; 2008 Apr; 31(4):657-64. PubMed ID: 18633177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study.
    Galzerano D; Tammaro P; Cerciello A; Breglio R; Mallardo M; Lama D; Tuccillo B; Capogrosso P
    J Hum Hypertens; 2004 Jan; 18(1):53-9. PubMed ID: 14688811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nifedipine and telmisartan for the treatment of hypertension: the TALENT study.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1499-503. PubMed ID: 22103868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal and vascular protective effects of telmisartan in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Sawada K
    Hypertens Res; 2006 Aug; 29(8):567-72. PubMed ID: 17137211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of telmisartan on arterial stiffness assessed by the cardio-ankle vascular index in hypertensive patients.
    Kinouchi K; Ichihara A; Sakoda M; Kurauchi-Mito A; Murohashi-Bokuda K; Itoh H
    Kidney Blood Press Res; 2010; 33(4):304-12. PubMed ID: 20664284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
    Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
    J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.
    Suksomboon N; Poolsup N; Prasit T
    J Clin Pharm Ther; 2012 Jun; 37(3):319-27. PubMed ID: 21848583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity.
    Huang GZ; Tang YH; Wang BY; Zhang B; Hu TJ; Zhang L; Zhang XY; Zhong Y
    Saudi Med J; 2011 Oct; 32(10):1017-21. PubMed ID: 22008920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.